Johnson & Johnson COVID-19 vaccine
The Latest
-
Johnson & Johnson Candidate COVID Drug Protects Hamsters From Severe Sickness
Drugmaker plans to launch its biggest experiment involving 60,000 human subjects by the end of September. Drugmaker plans to launch its biggest experiment involving 60,000 human subjects by the end of September. -
Johnson & Johnson Potential Coronavirus Drug Protects Primates With 1 Dose: Study
The experimental drug is the second vaccine prospect to show good results in monkeys this week. The experimental drug is the second vaccine prospect to show good results in monkeys this week.